Sotac Pharmaceuticals Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Sotac Pharmaceuticals Ltd is ₹ 111.3 as of 15 May 15:30 . The P/E Ratio of Sotac Pharmaceuticals Ltd changed from 31.3 on March 2024 to 16.4 on March 2025 . This represents a CAGR of -27.61% over 2 yearsThe P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Sotac Pharmaceuticals Ltd changed from ₹ 133.71 crore on March 2024 to ₹ 131.22 crore on March 2025 . This represents a CAGR of -0.94% over 2 yearsThe Market Cap of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The Revenue of Sotac Pharmaceuticals Ltd is ₹ 25.5 crore as of Jun '24 .The Revenue of Venmax Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Sotac Pharmaceuticals Ltd is ₹ 2.46 crore as of Jun '24 .The EBITDA of Venmax Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Sotac Pharmaceuticals Ltd is ₹ 1.35 crore as of Jun '24 .The Net Profit of Venmax Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 . The Dividend Payout of Sotac Pharmaceuticals Ltd changed from 13.94 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of 'M/s Sotac Pharmaceuticals', pursuant to a Deed of Partnership dated October 28, 2015.
Thereafter 'M/s.
Sotac Pharmaceuticals' was converted from Partnership Firm to a Private Limited Company in the name of 'Sotac Pharmaceuticals Private Limited' dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat.
Later on, Company converted into a Public Limited Company and the name of Company was changed to 'Sotac Pharmaceuticals Limited' dated November 22, 2022 issued by Registrar of Companies, Ahmedabad. The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis.

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

FAQs for the comparison of Sotac Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Sotac Pharmaceuticals Ltd or Venmax Drugs & Pharmaceuticals Ltd?

Market cap of Sotac Pharmaceuticals Ltd is 122 Cr while Market cap of Venmax Drugs & Pharmaceuticals Ltd is 26 Cr

What are the key factors driving the stock performance of Sotac Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd?

The stock performance of Sotac Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sotac Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd?

As of May 18, 2026, the Sotac Pharmaceuticals Ltd stock price is INR ₹111.3. On the other hand, Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹23.07.

How do dividend payouts of Sotac Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Sotac Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.